Background:

INSL4 encodes the Early placenta insulin-like peptide, a member of the insulin superfamily. INSL4 encodes a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. Expression of INSL4 products occurs within the early placental cytotrophoblast and syncytiotrophoblast.

Classification:

Primary antibody

Alternative names:

INSL4; Early placenta insulin-like peptide; EPIL; Insulin-like peptide 4; Placentin

Species reactivity:

Human

Host:

Rabbit

Isotype:

IgG

Immunogen:

The antiserum was produced against synthesized peptide derived from human INSL4. AA range:41-90

Concentration:

1 mg/ml

Molecular weight:

15445

Applications:

WB, IHC-p, IF, ELISA

Storage:

-20°C for one year

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com